• DEVENEZ MEMBRE
    Pour un accès complet à theheart.org
    À titre de membre permanent, vous pourrez accéder au contenu éditorial et de formation continue, utiliser le moteur de recherche, recevoir nos newsletters, participer aux discussions, télécharger des diapositives et plus encore.

    L'abonnement est gratuit !
    Inscrivez-vous maintenant !
    Obtenez un accès limité de 30 jours aux articles de heartwire
    Professionnel de la santé   Oui Non
    Obtenez un accès limité !

EuroPCR 2011 - Paris, France

Heartwire

The TAVI patient with CAD: Experts debate whether and when to do PCI
Interventional/Surgery
The TAVI patient with CAD: Experts debate whether and when to do PCI
May 20, 2011 14:00 EDT
If the screening process for TAVI turns up severe coronary disease, should that be treated, and if so, when? Or is it worth waiting to see if any chest pain and shortness of breath resolve after the valve is fixed?
SCAAR registry: Transradial PCI cuts mortality in STEMI
Interventional/Surgery
SCAAR registry: Transradial PCI cuts mortality in STEMI
10 COMMENTS - May 20, 2011 09:17 EDT
The retrospective analysis is based on over 25 374 STEMI patients treated in Sweden between 2005 and 2010. Experts called it "provocative," but not comparable to results from a randomized trial.
Less stent thrombosis with biodegradable vs permanent polymers: Meta-analysis
Thrombosis
Less stent thrombosis with biodegradable vs permanent polymers: Meta-analysis
May 20, 2011 06:10 EDT
CORRECTED // It's long been speculated, but never proven: now a new meta-analysis is offering the first solid proof that drug-eluting stents with bioerodable polymers are associated with less stent thrombosis and better clinical outcomes than stents with permanent polymers.
Interventional/Surgery
New SOURCE numbers bolster PARTNER results in real world
May 19, 2011 14:45 EDT
One-year survival for the entire SOURCE cohort (more than 2300 patients) was 76.5%, climbing to 80.1% in the transfemoral group and dipping to 74.2% in the transapical group.
Interventional/Surgery
TAVI spotlight swings to risks of paravalvular leaks
May 19, 2011 08:30 EDT
Having proved they have more or less attained device and procedural success, TAVI doctors are now peering more closely at the rate of paravalvular aortic regurgitation, and its not-insignificant impact on mortality.
Imaging
Adding function to CTA with "noninvasive FFR" ups accuracy, may cut procedures: DISCOVER FLOW
3 COMMENTS - May 18, 2011 09:30 EDT
At a time when arguments over the necessity of stent procedures and imaging tests are reaching a fever pitch, a new computer modeling system that can add functional information to a standard coronary CT angiography may once again shake up the world of diagnostic imaging and clinical decision making.
Poor clopidogrel responders with ACS face twofold risk of cardiac death: RECLOSE 2 ACS
Acute Coronary Syndromes
Poor clopidogrel responders with ACS face twofold risk of cardiac death: RECLOSE 2 ACS
Updated with video
2 COMMENTS - May 18, 2011 09:00 EDT
UPDATED WITH COMMENTARY // After a number of negative trials in stable coronary disease, the RECLOSE 2 ACS study, using light-transmittance aggregometry to assess platelet reactivity, shows that ACS nonresponders to clopidogrel face much higher rates of adverse ischemic events and cardiac death after PCI than responders and that doubling the clopidogrel dose doesn't improve their odds.
BASE-ACS: Could a bare-metal stent be
Interventional/Surgery
BASE-ACS: Could a bare-metal stent be "noninferior" to a leading DES?
May 17, 2011 16:30 EDT
A new twist on an old standard is causing ripples at EuroPCR 2011: a new titanium nitride-oxide-coated bare-metal stent has proved to be noninferior to a drug-eluting stent at 12 months.
Hypertension
Wider role for renal denervation considered, amid calls for more studies
May 17, 2011 12:15 EDT
Interventional cardiologists are mulling the potential new applications for renal denervation, even as they admit that the very limited data supporting the procedure in resistant hypertension need to be replicated in larger outcome studies.

Discussion and opinions

Blogs
Cutting-edge dialogues with Drs Tim Gardner and Mat Williams
Two cautionary notes on TAVI
May 27, 2011 10:00 EDT
Trials and PIs
XAMI with Dr SH Hofma
May 20, 2011 11:24 EDT
This week in cardiology from heartwire
#90: Cardiologist buys Arkansas Heart Hospital; FDA releases rosiglitazone REMS document; Fenofibrate panel; DISCOVER FLOW:...
May 20, 2011 10:30 EDT
Trials and PIs
NOYA I with Dr Runlin Gao
May 19, 2011 11:25 EDT
Trials and PIs
NEXT with Dr Didier Carrié
May 19, 2011 04:30 EDT
Trials and PIs
CLOSE-UP with Dr Neils Ramsing Holm
May 18, 2011 17:25 EDT
Trials and PIs
RECLOSE 2-ACS trial with Dr David Antoniucci
May 18, 2011 10:07 EDT

Editorial programs

Beyond TAVI
Editorial series
Beyond TAVI
Jul 4, 2011 11:55 EDT
In 2011, one out of two cases of biological aortic heart valve replacement in Europe is taking place via transcatheter procedure. Join Drs Martin Leon, Alain Cribier, Pieter Kappetein, and Stephan Windecker for a review of the rise of TAVI and a look into the future.
European perspectives on appropriate use of PCI
Editorial series
European perspectives on appropriate use of PCI
Jun 16, 2011 09:45 EDT
Allegations of inappropriate stenting in the US have fueled a storm that has challenged the integrity of various high-profile physicians and prompted some to doubt the widespread practice of stenting. What do European interventional cardiologists make of this debate? Join Drs Anthony Gershlick, Robert Byrne, Antonio Colombo, and Sunil Rao.
EuroPCR 2011 research highlights: A slideshow presentation
Editorial series
EuroPCR 2011 research highlights: A slideshow presentation
May 30, 2011 13:20 EDT
View our slideshow for results from the leading trials and most important debates from EuroPCR 2011. Featuring analysis of RECLOSE 2-ACS, DISCOVER FLOW, TAVI updates, renal denervation, BASE-ACS, SOURCE, DES meta-analysis, and the SCAAR registry.